# US 2012/0251443 A1 · Implantable contrast agents and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251443 A1
- Document ID: US20120251443A1
- Status: Published application
- Kind: A1
- Application number: 13/499,370
- Filed: 2010-10-01
- Published: 2012-10-04
- Earliest claimed: 2009-10-02
- Assignees: The Brigham and Women's Hospital, Inc.
- Inventors: C. Keith Ozaki; Jeffrey M. Karp; Frank Rybicki; Dimitrios Mitsouras; Praveen Kumar Vemula
- Web page: https://patentgrep.com/patent/US20120251443A1

## CPC

- A61K 49/1896: {not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present disclosure provides compositions and methods based on implantable contrast agents that are useful for imaging tissue and organs.

## Claims

### Claim at position 1

-2. (canceled)

### Claim 3

A method of labeling a tissue or organ ex vivo or in vivo, the method comprising contacting the tissue or organ with a contrast agent capable of binding to the tissue or organ of interest, under conditions sufficient for the contrast agent to be immobilized on the tissue or organ.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the organ of interest is part of the circulatory system.

### Claim 5 (depends on 3)

The composition of claim 3, wherein the contrast agent is an X-ray contrast agent, computed tomography (CT) contrast agent, single photon emission computed tomography (SPECT) contrast agent, positron emission tomography (PET) contrast agent, infrared contrast agent, magnetic resonance imaging (MRI) contrast agent, or fluorescent dye.

### Claim 6 (depends on 3)

The composition of claim 3, wherein the contrast agent comprises a metal chelator that chelates a detectable metal atom.

### Claim 7 (depends on 3)

The composition of claim 3, wherein the contrast agent is paramagnetic or radioactive.

### Claim 8 (depends on 3)

The composition of claim 3, wherein the contrast agent is a paramagnetic particle or ultra-small paramagnetic particle.

### Claim 9 (depends on 3)

The composition of claim 3, wherein the contrast agent is immobilized on the tissue or organ via a covalent or non-covalent bond.

### Claim 10 (depends on 3)

The method of claim 3, wherein the method is carried out during, or as part of, a surgical procedure.

### Claim 11 (depends on 3)

The composition of claim 3, wherein the tissue or organ comprises a functional group that is selected from the group consisting of an amino group, a thiol group, or a hydroxyl group.

### Claim 12 (depends on 3)

The composition of claim 3, wherein the contrast agent comprises a functional group that is suitable for reacting with a functional group present on the tissue or organ.

### Claim at position 12

-16. (canceled)
